《半日速報》恆指半日收報24,745點 跌17點; 恆生科技指數半日收報6,174點 跌19點 藥明生物升逾8%
恆指半日收24,745點,跌17點或0.1%。恆生科技指數報6,174點,跌19點或0.3%。國指跌5點或0.1%,報8,788點。
活躍重磅股表現:
港交所(00388.HK) 收462.2元,下跌1%;
友邦(01299.HK) 收85.5元,下跌0.8%;
騰訊(00700.HK) 收462元,下跌0.4%;
美團(03690.HK) 收270.4元,下跌0.3%;
平安(02318.HK) 收56.3元,上升0.2%;
阿裏巴巴(09988.HK) 收157.4元,上升0.1%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收100.9元,上升8.4%;
京東健康(06618.HK) 收74元,上升5%;
碧桂園(02007.HK) 收6.82元,下跌3.4%;
舜宇(02382.HK) 收199元,下跌3.4%;
異動綜合中小型股:
開拓藥業-B(09939.HK) 收46.4元,上升18.1%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.